• Cordlife's third-quarter loss widened 26% year-on-year to S$ 3.13 million, while revenue fell 23% to S$ 7.89 million.
• Nine-month loss narrowed 18% year-on-year to S$ 5.79 million, while revenue declined 14% to S$ 25.18 million.
• Operating activities used S$ 263,000 over nine months, reversing a year-earlier inflow.
• Singapore cord blood banking operations remain restricted to existing units under license conditions running through January 13, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cordlife Group Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 5MVYLB31UE6ERM2K) on November 13, 2026, and is solely responsible for the information contained therein.